CLDN4 and breast carcinoma: The distinctive prognostic significance of claudin-3 and claudin-4 in triple-negative and luminal types of breast cancer was analyzed in a recent report [141] in which positive expression of claudin-3 was associated with poor prognostic factors, whereas claudin-4 expression was related to better prognostic factors in TNBCs.